Melissa Seventko
Family · Richmond, VANPI 1184398505
Payments from drug & device makers
Across 247 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$806
- Novo Nordisk$720
- Amneal Pharmaceuticals LLC$424
- Amgen$395
- Sanofi-aventis U.S. LLC$220
- Esperion Therapeutics, Inc.$170
- plus $2K from 35 others
What the payments were for
- Food & beverage$4,772100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 39 | $806 |
| Novo Nordisk | 48 | $720 |
| Amneal Pharmaceuticals LLC | 25 | $424 |
| Amgen(2 entities) | 15 | $395 |
| Sanofi-aventis U.S. LLC | 10 | $220 |
| Esperion Therapeutics, Inc. | 10 | $170 |
| Xeris Pharmaceuticals, Inc. | 7 | $157 |
| Insulet Corporation | 4 | $129 |
| AstraZeneca(2 entities) | 7 | $126 |
| Antares Pharma, Inc. | 6 | $120 |
| Tolmar, Inc. | 7 | $119 |
| IBSA Pharma Inc. | 5 | $119 |
| Boehringer Ingelheim | 5 | $105 |
| Radius Health, Inc. | 5 | $104 |
| Novartis | 4 | $84 |
| Dexcom, Inc. | 3 | $77 |
| Medtronic | 4 | $71 |
| Mannkind Corporation | 3 | $64 |
| Recordati_rare_diseases_inc. | 3 | $59 |
| Bayer | 3 | $53 |
| Lifescan, Inc. | 2 | $49 |
| Pfizer | 2 | $47 |
| Cequr Corporation | 2 | $47 |
| BETA Bionics, Inc. | 3 | $46 |
| Amarin Pharma, Inc. | 2 | $43 |
| AbbVie | 2 | $42 |
| Astellas Pharma US Inc | 2 | $40 |
| Kyowa Kirin, Inc. | 2 | $40 |
| Merck | 2 | $39 |
| Ascendis Pharma Endocrinology Inc | 2 | $36 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Corcept Therapeutics | 1 | $24 |
| Verity Pharmaceuticals Inc. | 1 | $22 |
| Nevro Corp. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
| Clarus Therapeutics Inc. | 2 | $16 |
| Boston Scientific | 1 | $14 |
| Zealand Pharma US, Inc. | 1 | $14 |
| Halozyme Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$128
How this compares
$4,772 in reported general payments places this provider in the 90th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 109 | $194,750 |
| MounjaroTirzepatide | 106 | $173,029 |
| JardianceEmpagliflozin | 74 | $101,610 |
| TrulicityDulaglutide | 64 | $82,408 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $28,492 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $20,136 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $17,409 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $15,435 |
| Humalog Kwikpen U-100Insulin Lispro | 21 | $10,626 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 56 | $10,040 |
| JanuviaSitagliptin Phosphate | 11 | $9,745 |
| Novolog FlexpenInsulin Aspart | 22 | $6,044 |
| NovologInsulin Aspart | 13 | $5,186 |
| SynthroidLevothyroxine Sodium | 85 | $4,400 |
| Humulin NInsulin Nph Human Isophane | 11 | $1,976 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humulin N | $806 | $257,413181 claims |
| Novo NordiskOzempic, Novolog | $720 | $199,936122 claims |
| Boehringer IngelheimJardiance | $105 | $101,61074 claims |
| MerckJanuvia | $39 | $9,74511 claims |
| AbbVieSynthroid, Armour Thyroid | $42 | $5,22697 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $424 | $1,627165 claims |
| PfizerLevoxyl | $47 | $31124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,332 family providers in Virginia.
Other family in Richmond
- Hochong Smith GillesRichmond$131K
- Kasiah BanksRichmond$29K
- Johanna ChristensenRichmond$24K
- Megan ZoltyRichmond$11K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Sean OlaughlinMidlothian$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.